Polymer Embolism from Bioactive and Hydrogel Coil Embolization Technology: Considerations for Product Development

REFERENCES

1. 1.↵
   2. Reinges MH,
   3. Krings T,
   4. Drexler AY, et al

   . Bare, bio-active and hydrogel-coated coils for endovascular treatment of experimentally induced aneurysms: long-term histological and scanning electron microscopy results. Interv Neuroradiol 2010;16:139–50 doi:10.1177/159101991001600205 pmid:20642888

   CrossRefPubMed
2. 2.↵
   2. Killer M,
   3. Arthur AS,
   4. Barr JD, et al

   . Histomorphology of thrombus organization, neointima formation, and foreign body response in retrieved human aneurysms treated with hydrocoil devices. J Biomed Mater Res B Appl Biomater 2010;94:486–92 doi:10.1002/jbm.b.31660 pmid:20574973

   CrossRefPubMed
3. 3.↵
   2. Chopra AM,
   3. Mehta M,
   4. Bismuth J, et al

   . Polymer coating embolism from intravascular medical devices: a clinical literature review. Cardiovasc Pathol 2017;30:45–54 doi:10.1016/j.carpath.2017.06.004 pmid:28759819

   CrossRefPubMed
4. 4.↵
   U.S. Food and Drug Administration Safety Communications. Lubricious Coating Separation from Intravascular Medical Devices: FDA Safety Communication. November 23, 2015. http://wayback.archive-it.org/7993/20170404182155/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm473794.htm. Accessed January 13, 2019.
5. 5.↵
   U.S. Food and Drug Administration. Recognized Consensus Standards. Recognition number 3–99, AAMI TIR42:2010. Evaluation of Particulates Associated with Vascular Medical Devices. Updated September 17, 2018. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/detail.cfm?standard__identification_no=38909. Accessed 13 January 13, 2019.